BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 25036445)

  • 1. Expression of VEGF-A, HIF-1 A, CD34 and Ki67 in clear cell renal cell carcinomas and their relationship with conventional prognostic markers.
    Bürgesser MV; Riva V; Ojeda SM; Muñoz Morales D; Calafat P; Diller A
    Rev Fac Cien Med Univ Nac Cordoba; 2014; 71(1):7-15. PubMed ID: 25036445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of various potential prognostic markers and survival data in clear cell renal cell carcinoma.
    Ebru T; Fulya OP; Hakan A; Vuslat YC; Necdet S; Nuray C; Filiz O
    Int Braz J Urol; 2017; 43(3):440-454. PubMed ID: 27583351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up.
    Minardi D; Lucarini G; Filosa A; Milanese G; Zizzi A; Di Primio R; Montironi R; Muzzonigro G
    Int J Immunopathol Pharmacol; 2008; 21(2):447-55. PubMed ID: 18547492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical investigation of the angiogenic proteins VEGF, HIF-1α and CD34 in invasive ductal carcinoma of the breast.
    Maschio LB; Madallozo BB; Capellasso BA; Jardim BV; Moschetta MG; Jampietro J; Soares FA; Zuccari DA
    Acta Histochem; 2014 Jan; 116(1):148-57. PubMed ID: 23899963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
    Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
    Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the vascular density of VEGF expression with microvascular density determined with CD34 and CD31 staining and conventional prognostic markers in renal cell carcinoma.
    Yilmazer D; Han U; Onal B
    Int Urol Nephrol; 2007; 39(3):691-8. PubMed ID: 17180739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
    Wiesener MS; Münchenhagen PM; Berger I; Morgan NV; Roigas J; Schwiertz A; Jürgensen JS; Gruber G; Maxwell PH; Löning SA; Frei U; Maher ER; Gröne HJ; Eckardt KU
    Cancer Res; 2001 Jul; 61(13):5215-22. PubMed ID: 11431362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expressions of hypoxia inducible factor-1alpha and vascular endothelial growth factor in human renal cell carcinoma].
    Shao ZQ; Zheng SB; Xiao YJ; Tan WL; Chen T; Qi H; Jiang YD; Yu ZC; Zhang HJ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):1034-6. PubMed ID: 16109571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of hypoxia inducible factor-1α and 2α in conventional renal cell carcinoma with or without sarcomatoid differentiation.
    Ku JH; Park YH; Myung JK; Moon KC; Kwak C; Kim HH
    Urol Oncol; 2011; 29(6):731-7. PubMed ID: 19914104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival in patients with clear cell renal cell carcinoma is predicted by HIF-1α expression.
    Minardi D; Lucarini G; Santoni M; Mazzucchelli R; Burattini L; Conti A; Principi E; Bianconi M; Scartozzi M; Milanese G; Di Primio R; Montironi R; Cascinu S; Muzzonigro G
    Anticancer Res; 2015 Jan; 35(1):433-8. PubMed ID: 25550584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of vascular endothelial growth factor and hypoxia-inducible factor-1α expression with pathological renal artery changes in patients with renal cell carcinoma.
    Demirović A; Tomas D; Tomić K; Spajić B; Ibukić A; Cupić H; Krušlin B
    Scand J Urol; 2014 Feb; 48(1):34-40. PubMed ID: 24256617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of nuclear FIH independently predicts overall survival of clear cell renal cell carcinoma patients.
    Kroeze SG; Vermaat JS; van Brussel A; van Melick HH; Voest EE; Jonges TG; van Diest PJ; Hinrichs J; Bosch JL; Jans JJ
    Eur J Cancer; 2010 Dec; 46(18):3375-82. PubMed ID: 20709525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-inducible factor 1alpha expression in renal cell carcinoma analyzed by tissue microarray.
    Lidgren A; Hedberg Y; Grankvist K; Rasmuson T; Bergh A; Ljungberg B
    Eur Urol; 2006 Dec; 50(6):1272-7. PubMed ID: 16814458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
    Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
    J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of hypoxia inducible factor-1alpha and its downstream molecules in sarcomatoid renal cell carcinoma.
    Tickoo SK; Alden D; Olgac S; Fine SW; Russo P; Kondagunta GV; Motzer RJ; Reuter VE
    J Urol; 2007 Apr; 177(4):1258-63. PubMed ID: 17382701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in patients with clear cell renal cell carcinoma.
    Minardi D; Santoni M; Lucarini G; Mazzucchelli R; Burattini L; Conti A; Bianconi M; Scartozzi M; Milanese G; Primio RD; Montironi R; Cascinu S; Muzzonigro G
    Urol Oncol; 2015 Mar; 33(3):113.e1-7. PubMed ID: 25069421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of BNIP3 and its correlations to HIF-1alpha and VEGF in clear cell renal cell carcinoma].
    Luo L; Xiong ZB; Zeng H; Chen N; Chen XQ; Zhang P; Li X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 43(1):79-82. PubMed ID: 22455137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear expression of hypoxia-inducible factor-1alpha in clear cell renal cell carcinoma is involved in tumor progression.
    Di Cristofano C; Minervini A; Menicagli M; Salinitri G; Bertacca G; Pefanis G; Masieri L; Lessi F; Collecchi P; Minervini R; Carini M; Bevilacqua G; Cavazzana A
    Am J Surg Pathol; 2007 Dec; 31(12):1875-81. PubMed ID: 18043042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
    Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
    Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
    Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.